EndyMed Medical Ranked Number One - Fastest Growing Biotech/Pharmaceutical Company on the Deloitte Technology Fast 500 EMEA 2013

• 

"We congratulate EndyMed Medical on being one of the 500 fastest growing technology companies in the region," said David Halstead, Deloitte United Kingdom, partner in charge of the Deloitte Technology Fast 500 EMEA program.

Caesarea, Israel (PRWEB) December 04, 2013

EndyMed Medical today announced that it ranked Number One on Fastest Growing Biotech/Pharmaceutical Sector and number 25 among all Deloitte's Technology Fast 500 EMEA 2013, ranking of the 500 fastest growing technology companies in EMEA. Rankings are based on percentage revenue growth over five years. EndyMed Medical grew 4217 percent during this period.

EndyMed Medical's CEO, Uzi Blumensohn, credits EndyMed's revolutionary 3DEEP® RF treatment technology and tremendous determination to become a major entity in the extremely competitive medical aesthetics market with the company’s 4217 % revenue growth over the past five years. He said, "We are very proud to be ranked first in our sector on the Deloitte Technology Fast 500 EMEA 2013. It's a great achievement, recognizing the complete dedication and exceptional hard work of the management and staff of EndyMed over the past 5 years. We started with a conviction that our proprietary 3DEEP technology would revolutionize the aesthetic radiofrequency treatment market, and we succeeded in making a name for ourselves in the industry."

"Making the Deloitte Technology Fast 500 is commendable in today’s highly competitive technology industry," said David Halstead, Deloitte United Kingdom, partner in charge of the Deloitte Technology Fast 500 EMEA program. "We congratulate EndyMed Medical on being one of the 500 fastest growing technology companies in the region."

“Achieving sustained revenue growth of 4217% over five years is a tremendous achievement,” said David Halstead, Deloitte United Kingdom and partner in charge of the Deloitte Technology Fast 500 EMEA program. “EndyMed Medical’s phenomenal growth puts it in select company.”

Deloitte Technology Fast 500 EMEA selection and qualifications
The Technology Fast 500 list is compiled from the Deloitte EMEA Technology Fast 50 programmes, nominations submitted directly to the Technology Fast 500, and public company database research. To qualify for the Technology Fast 500, entrants must have had base-year operating revenues of at least €50,000 and current-year operating revenues of at least €800,000.

Entrants must also be public or private companies headquartered in EMEA and must be a “technology company,” defined as a company that develops or owns proprietary technology that contributes to a significant portion of the company's operating revenues; or manufactures a technology-related product; or devotes a high percentage of effort to the research and development of technology. Using other companies' technology in a unique way does not qualify.

About EndyMed Medical
EndyMed Medical Ltd., established in 2007, offers energy based aesthetic treatment systems for the professional markets. EndyMed's proprietary 3DEEP® radiofrequency technology is a unique solution for fractional and non-ablative wrinkle treatment, skin tightening on both the face and body, body contouring and acne scar treatment. Through the three dimensional interaction of multiple RF sources, 3DEEP® RF creates deep thermal patterns in the tissue which is a novel and effective approach to aesthetic treatments. This technology is implemented also in Endymed's NEWA home use skin tightening device, the first and only RF based energy device to be cleared by the FDA for wrinkle reduction.For more information, please see our website at http://www.endymed.com and http://www.mynewa.com.

EndyMed Medical's 3DEEP® Technology
Used by some of the world's top dermatologists and plastic surgeons, EndyMed's FDA cleared, patented 3DEEP radiofrequency (RF) technology is the safest and most effective technology available today for wrinkle reduction and skin tightening. Multiple positive and negative electrodes work together in a highly controlled way, enabling precisely targeted energy delivery. The energy is directed vertically into the deep dermal tissue, so that very little energy flows along the skin's surface. This keeps the skin relatively cool, while achieving the deep-skin heating necessary to optimize production of new collagen.

About Deloitte Technology Fast 500™ EMEA
The Deloitte Technology Fast 500 EMEA program is the region’s most objective industry-ranking to focus on the technology field, recognizing technology companies that have achieved the fastest rates of revenue growth in Europe, the Middle East, and Africa (EMEA) during the past five years. Combining technological innovation, entrepreneurship and rapid growth, Fast 500 companies – large, small, public and private – span a variety of industry sectors, and are leaders in hardware, software, telecom, semiconductors, internet, media, life sciences and emerging areas, such as clean technology.

The program is supported by the Deloitte Technology Fast 50 initiatives, which rank high growth technology companies by location or specifically defined geographic area and is run by the Deloitte Touche Tohmatsu Limited’s Technology, Media & Telecommunications (TMT) global industry group. Co-sponsors include Ciklum,a leading supplier of technical personnel and teams, software development and agile business consulting to high growth companies, Fidelity Growth Partners Europe, a venture and growth capital investor which backs entrepreneurs with aspiration for greatness in the IT and clean technology sectors across Europe, Silicon Valley Bank, the premier bank for technology, life science, private equity and premium wine businesses and Taylor Wessing, a leading International law firm with a focus on the industries of tomorrow,. More information on the programme and prior year winners is available on http://www.deloitte.com/fast500emea

About Deloitte
Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee, and its network of member firms, each of which is a legally separate and independent entity. Please see http://www.deloitte.com/about for a detailed description of the legal structure of Deloitte Touche Tohmatsu Limited and its member firms.

Deloitte provides audit, tax, consulting, and financial advisory services to public and private clients spanning multiple industries. With a globally connected network of member firms in more than 150 countries, Deloitte brings world-class capabilities and high-quality service to clients, delivering the insights they need to address their most complex business challenges. Deloitte has in the region of 200,000 professionals, all committed to becoming the standard of excellence.

PDF Print